Strategy for Universities, Research Institutions and Government Laboratories
For research clients, there are three major options available for commercialization of a new technology - license now, add value and license later, or establish a spin-off company. The investment called for, and the potential revenue to the research client, vary greatly when choosing between the three alternatives. Alta Biomedical will analyze the three alternatives, reviewing available resources, the investment required, and the potential return.
License now: Alta Biomedical will assist in:
- Identifying potential licensees
- Coaching the research staff
- Placing a value on the technology
- Negotiating terms of license agreements
- Drafting agreements
Add value and license later: If potential products are taken through the prototype or clinical development phase, potential royalty income can increase substantially. This can require significant additional investment of time and money. Alta Biomedical will help assess and manage the opportunity, assisting as with the "License now" alternative, and also:
- Reviewing the planned product
- Assessing the value added, and the resources needed
- Setting up milestones for prototype or clinical development
- Managing the process
Establish a spin-off company to develop and market the products. This is the most elaborate, expensive and potentially most lucrative alternative. Alta Biomedical will help assess the basis for, and establish the new corporation by:
- Market analysis
- Competitor analysis
- Resource requirement and funding analysis
- Financial projections
- Team building
- Writing a mini-business plan for the new entity
- Investor identification
- Interim management
|
|
|
|
|
|
|
|
